{
  "source": "PA-Med-Nec-Ophthalmic-Agents-Qlosi-Vuity.txt",
  "chunks": [
    "UnitedHealthcare Pharmacy\nClinical Pharmacy Programs\nProgram Number 2025 P 2266-4\nProgram Prior Authorization/Medical Necessity\nMedication Qlosi (pilocarpine)™ 0.4% ophthalmic solution, Vuity® (pilocarpine)\n1.25% ophthalmic solution\nP&T Approval Date 3/2022, 3/2023, 1/2024, 1/2025\nEffective Date 4/1/2025\n1. Background:\nQlosi (pilocarpine) 0.4% ophthalmic solution and Vuity (pilocarpine) 1.25% ophthalmic\nsolution are indicated for the treatment of presbyopia in adults. The efficacy of Qlosi was\nestablished in clinical trials with patients aged 45 to 64 years of age with presbyopia and for\nVuity in patients aged 40 to 55 years of age with presbyopia. The standard of therapy for the\ntreatment of presbyopia is use of corrective lenses, such as glasses and contact lenses, or\nrefractive surgery.\n2. Coverage Criteriaa:\nA. Treatment of Presbyopia\nQlosi or Vuity is not considered medically necessary for the treatment of presbyopia based on\nthe definition of medically necessary health care services in the certificate of coverage.\nAll requests for authorization will be denied.\na State mandates may apply. Any federal regulatory requirements and the member specific benefit\nplan coverage may also impact coverage criteria. Other policies and utilization management\nprograms may apply.\n3. Additional Clinical Rules:\n• Notwithstanding Coverage Criteria, UnitedHealthcare may approve initial and re-\nauthorization based solely on previous claim/medication history, diagnosis codes (ICD-10)\nand/or claim logic. Use of automated approval and re-approval processes varies by program\nand/or therapeutic class.\n• Supply limits may be in place.\n4. References:\n1. Qlosi [package insert]. Ponte Vedra, FL: Orasis Pharmaceuticals, Ltd.; June 2024..\n2. Vuity [package insert]. North Chicago, IL: AbbVie Inc.; March 2023.\n2. Mian, SI. Visual impairment in adults: Refractive disorders and presbyopia. In: UpToDate,\nGardiner, MF, UpToDate, Waltham, MA, 2024.\n© 2025 UnitedHealthcare Services Inc.\n1\nProgram Pri",
    " March 2023.\n2. Mian, SI. Visual impairment in adults: Refractive disorders and presbyopia. In: UpToDate,\nGardiner, MF, UpToDate, Waltham, MA, 2024.\n© 2025 UnitedHealthcare Services Inc.\n1\nProgram Prior Authorization/Medical Necessity – Qlosi, Vuity\nChange Control\nDate Change\n3/2022 New program\n3/2023 Annual review. Updated references.\n1/2024 Added Qlosi. Updated references.\n1/2025 Annual review. Updated references.\n© 2025 UnitedHealthcare Services Inc.\n2"
  ]
}